Regencell Bioscience Holdings Limited Ordinary Shares RGC
$9.71
+2.00%
at last close
Market Cap$4.72 billion
P/E Ratio—
Div Yield9.06%
Volume329.5K
52-Week Range
$4.51$69.00
Key Stats
- Today's Range
- $9.15 – $10.33
- 50-Day Range
- $4.91 – $11.12
- 52-Week Range
- $4.51 – $69.00
- Volume
- 330K shs
- Average Volume
- 263K shs
- Market Cap
- $4.72 billion
- P/E Ratio
- —
- Dividend Yield
- 9.06%
Dividend
- Dividend Yield
- 9.06%
- Annual Dividend
- $0.88
- Payout Ratio
- —
- Ex-Dividend Date
- 2018-02-15
Short Interest
- Short Interest
- 2.94%
- Days to Cover
- 3.08
About Regencell Bioscience Holdings Limited Ordinary Shares
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
Related Stocks
Compare head-to-head: RGC vs NVDA·RGC vs AAPL·RGC vs GOOGL·RGC vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.